Chest Seal Wound Dressing Supply

The contract calls for the manufacture and supply of 40 units of sterile, latex-free, transparent chest seal dressings equipped with a one-way valve, designed to meet rigorous military medical specifications and Department of Defense Logistics Agency requirements. These dressings are intended for use in combat and field medical scenarios, where rapid deployment and reliable performance are critical to managing open chest wounds and preventing tension pneumothorax. All units must comply with stringent quality and performance standards to ensure safety, durability, and effectiveness under extreme conditions, with full traceability and documentation required for military procurement compliance. The solicitation is issued as a subcontract under the NAICS code 339113, targeting medical device manufacturers capable of fulfilling defense-grade production demands. Responses are due by July 27, 2026, with performance expected to be delivered to Nellis Air Force Base in Nevada, 89191. The contract falls under the Medical Supply Chain MD Surg FSF, part of the broader Department of Defense supply infrastructure, and emphasizes adherence to military logistics protocols including packaging, labeling, and shipping standards. While the exact award timing and payment terms are unspecified, successful bidders must demonstrate proven capability in producing FDA-cleared or equivalent medical devices for military use, with prior experience in DLA contract execution strongly preferred.